Concepedia
Statistics
Publications
3
Citations
122
H-Index
Active since
2018
Affiliations
Rutgers, The State University of New Jersey(Current)
Johnson University
Memorial Sloan Kettering Cancer Center
Aditya Thandoni is an author at Rutgers, The State University of New Jersey specializing in oncology, cancer pharmacology, and medicine.
Publications per year
2018–2023
VX-984 is a selective inhibitor of non-homologous end joining, with possible preferential activity in transformed cells
Atif J. Khan, Sarah M. Misenko, Aditya Thandoni et al. · Oncotarget · 2018 · 55 citations · Full text
Life Sciences, Molecular Biology, Oncology +17
Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancer
Shang-Jui Wang, Aditya Thandoni, Praveen K. Bommareddy et al. · Journal for ImmunoTherapy of Cancer · 2023 · 35 citations · Full text
Medicine, Immunology, Oncology +17
The glutamate release inhibitor riluzole increases DNA damage and enhances cytotoxicity in human glioma cells, <i>in vitro</i> and <i>in vivo</i>
Atif J. Khan, Stephanie LaCava, Monal Mehta et al. · Oncotarget · 2019 · 32 citations · Full text
Medicine, Oncology, Pharmacology +17
1–3 of 3